1. Home
  2. EXAS vs AFG Comparison

EXAS vs AFG Comparison

Compare EXAS & AFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • AFG
  • Stock Information
  • Founded
  • EXAS 1995
  • AFG 1872
  • Country
  • EXAS United States
  • AFG United States
  • Employees
  • EXAS N/A
  • AFG N/A
  • Industry
  • EXAS Medical Specialities
  • AFG Property-Casualty Insurers
  • Sector
  • EXAS Health Care
  • AFG Finance
  • Exchange
  • EXAS Nasdaq
  • AFG Nasdaq
  • Market Cap
  • EXAS 10.7B
  • AFG 10.3B
  • IPO Year
  • EXAS N/A
  • AFG N/A
  • Fundamental
  • Price
  • EXAS $56.13
  • AFG $124.80
  • Analyst Decision
  • EXAS Strong Buy
  • AFG Hold
  • Analyst Count
  • EXAS 20
  • AFG 4
  • Target Price
  • EXAS $70.68
  • AFG $138.75
  • AVG Volume (30 Days)
  • EXAS 3.3M
  • AFG 443.7K
  • Earning Date
  • EXAS 07-30-2025
  • AFG 05-06-2025
  • Dividend Yield
  • EXAS N/A
  • AFG 7.31%
  • EPS Growth
  • EXAS N/A
  • AFG N/A
  • EPS
  • EXAS N/A
  • AFG 9.52
  • Revenue
  • EXAS $2,828,128,000.00
  • AFG $7,984,000,000.00
  • Revenue This Year
  • EXAS $14.58
  • AFG N/A
  • Revenue Next Year
  • EXAS $12.75
  • AFG $7.00
  • P/E Ratio
  • EXAS N/A
  • AFG $13.09
  • Revenue Growth
  • EXAS 11.57
  • AFG 4.76
  • 52 Week Low
  • EXAS $39.97
  • AFG $114.73
  • 52 Week High
  • EXAS $72.83
  • AFG $150.19
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 60.75
  • AFG 50.62
  • Support Level
  • EXAS $55.26
  • AFG $120.52
  • Resistance Level
  • EXAS $58.68
  • AFG $123.72
  • Average True Range (ATR)
  • EXAS 1.99
  • AFG 2.18
  • MACD
  • EXAS -0.27
  • AFG 0.09
  • Stochastic Oscillator
  • EXAS 62.66
  • AFG 61.94

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About AFG American Financial Group Inc.

American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The company also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. The company's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.

Share on Social Networks: